Savient Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 5 of about 5   

Articles published

SVNTQ 0.0019
price chart
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer
That's been tough, Cautreels says, in part because of the immunogenicity associated with the approach. One company, Bridgewater, NJ-based Savient Pharmaceuticals, won FDA approval of such a drug, called pegloticase (Krystexxa), in 2010. For various ...
Related articles »  
Large Volume Wearable Injectors - 2nd Edition
This development is being led jointly by established firms such as Becton Dickinson, West Pharmaceuticals and emerging players such as Unilife, SteadyMed Therapeutics, Ratio Drug Delivery, Sensile Medical, Enable Injections and scPharmaceuticals.